Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole versus amphotericin B plus flucytosine for peritoneal dialysis-related fungal peritonitis
TCTR20210316001Phase 3Unknown
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole, amphotericin b, flucytosine in fungal peritonitis, sponsored by Ratchadaphiseksomphot Endowment Fund. Status: unknown.
02
Drugs
voriconazoleamphotericin bflucytosine
03
Conditions
fungal peritonitis
Beyond the preview
Go deeper on TCTR20210316001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210316001.